125 related articles for article (PubMed ID: 6889881)
21. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
22. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine.
Fletcher PJ; Selhi ZF; Azampanah A; Sills TL
Neuropsychopharmacology; 2001 Apr; 24(4):399-409. PubMed ID: 11182535
[TBL] [Abstract][Full Text] [Related]
23. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
Willoughby JO; Menadue M; Jervois P
Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
[TBL] [Abstract][Full Text] [Related]
24. Effect of selective midbrain and diencephalic 5,7-dihydroxytryptamine lesions on serotonin content in individual preopticohypothalamic nuclei and on serum luteinizing hormone level.
van de Kar LD; Lorens SA; Vodraska A; Allers G; Green M; Van Orden DE; Van Orden LS
Neuroendocrinology; 1980 Nov; 31(5):309-15. PubMed ID: 7442933
[TBL] [Abstract][Full Text] [Related]
25. Effects of p-chloroamphetamine and 5,7-dihydroxytryptamine on the sexual behavior of gonadectomized male and female rats.
Södersten P; Berge OG; Hole K
Pharmacol Biochem Behav; 1978 Oct; 9(4):499-508. PubMed ID: 733836
[TBL] [Abstract][Full Text] [Related]
26. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
27. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
[TBL] [Abstract][Full Text] [Related]
28. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
[TBL] [Abstract][Full Text] [Related]
29. Intrahypothalamic 5,7-dihydroxytryptamine facilitates feminine sexual behavior and decreases [3H]imipramine binding and 5-HT uptake.
Luine VN; Frankfurt M; Rainbow TC; Biegon A; Azmitia E
Brain Res; 1983 Apr; 264(2):344-8. PubMed ID: 6850308
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
31. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
32. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
Lucot JB; Seiden LS
Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
Hutson PH; Tricklebank MD; Curzon G
Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
[TBL] [Abstract][Full Text] [Related]
34. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
35. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine.
Sijbesma H; Schipper J; de Kloet ER; Mos J; van Aken H; Olivier B
Pharmacol Biochem Behav; 1991 Feb; 38(2):447-58. PubMed ID: 1829232
[TBL] [Abstract][Full Text] [Related]
36. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
Kantak KM; Hegstrand LR; Eichelman B
Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
[TBL] [Abstract][Full Text] [Related]
37. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructure of the regenerating growth cones of catecholamine nerve terminals in rat hypothalamic nuclei after 5,7-dihydroxytryptamine administration.
Chiba T; Murata Y; Shibata H
Brain Res; 1982 Apr; 238(2):407-12. PubMed ID: 7093661
[TBL] [Abstract][Full Text] [Related]
39. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
40. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
